[1]
|
Tracy, R.P. (2003) Thrombin, Inflammation and Cardiovascular Disease. Chest, 124, 49S-57S. http://dx.doi.org/10.1378/chest.124.3_suppl.49S
|
[2]
|
Braunwald, E. (2008) Review Article: Biomarkers in Heart Failure. New England Journal of Medicine, 358, 2148-2159. http://dx.doi.org/10.1056/NEJMra0800239
|
[3]
|
Egashira, K. (2003) Molecular Mechanisms Mediating Inflammation in Vascular Disease: Special Reference to Monocyte Chemoattractant Protein-1. Hypertension, 41, 834-841. http://dx.doi.org/10.1161/01.HYP.0000051642.65283.36
|
[4]
|
Hansson, G.K. (2005) Review Article: Inflmmation, Atherosseclerosis and Coronary Artery Disease. New England Journal of Medicine, 352, 1685-1695. http://dx.doi.org/10.1056/NEJMra043430
|
[5]
|
Padovani, J.C., Pazin-Filho, A., Simoes, M.V., Marin-Neto, J.A., Zago, M.A. and Franco, R.F. (2000) Gene Polymorphisms in the TNF Locus and the Risk of Myocardial Infarction. Thrombosis Research, 100, 263-269. http://dx.doi.org/10.1016/S0049-3848(00)00315-7
|
[6]
|
Pearson, T.A., George, A., Mensah, G.A., Alexander, R.W., Anderson, J.L., Cannon, R.O., et al. (2003) Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice; A Statement for Healthcare Professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107, 499-511. http://dx.doi.org/10.1161/01.CIR.0000052939.59093.45
|
[7]
|
Calabrese, F., Elisa, C., Cristina, C., et al. (2004) Over Expression of Tumor Necrosis Factor (TNF-a) and TNF-a Receptor-1 in Human Viral Myocarditis: Clinicopathologic Correlations. Mordern Pathology, 17, 1108-1118. http://dx.doi.org/10.1038/modpathol.3800158
|
[8]
|
Levine, B., Kalman, J., Mayer, L., et al. (1990) Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure. New England Journal of Medicine, 323, 236-241. http://dx.doi.org/10.1056/NEJM199007263230405
|
[9]
|
Elahi, M.M. and Matata, B.M. (2005) Genetic Diversity of Tumour Necrosis Factor: Implications on Cardiovascular Complications of Polymorphisms at Position –308 in the Promoter Region. The Cardiology, 1, 179-188.
|
[10]
|
Brinkman, B.M. (1996) Relevance of the Tumor Necrosis Factor Alpha (TNF Alpha) –308 Promoter Polymorphism in TNF Alpha Gene Regulation. Journal of Inflammation, 46, 32-41.
|
[11]
|
Patel, R., Lim, D.S., Reddy, D., Nagueh, S.F., Lutucuta, S., Sole, M.J., et al. (2000) Variants of Trophic Factors and Expression of Cardiac Hypertrophy in Patients with Hypertrophic Cardiomyopathy. Journal of Molecular and Cellular Cardiology, 32, 2369-2377. http://dx.doi.org/10.1038/sj.ejhg.5201816
|
[12]
|
Mellick, G.D. (2007) TNF Gene Polymorphism and Quantitative Trait Related to Cardiovascular Diseases: Getting to the Heart of the Matter. European Journal of Human Genetics, 15, 609-611. http://dx.doi.org/10.1038/sj.ejhg.5201816
|
[13]
|
Deswal, A., Petersen, N.J., Feldman, A.M., Young, J.B., White, B.G. and Mann, D.L. (2001) Cytokines and Cytokine Receptors in Advanced Heart Failure: An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST). Circulation, 103, 2055-2059. http://dx.doi.org/10.1161/01.CIR.103.16.2055
|
[14]
|
Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J.B. and Manna, D.L. (1996) Proinflammatory Cytokine Levels in Patients with Depressed Left Ventricular Ejection Fraction: A Report from the Studies of Left Ventricular Dysfunction (SOLVD). Journal of American College of Cardiology, 27, 1201-1206. http://dx.doi.org/10.1016/0735-1097(95)00589-7
|
[15]
|
Kubota, T., McNamara, D.M., Wang, J.J., Trost, M., McTiernan, C.F., Mann, D.L., et al. (1998) Effects of Tumor Necrosis Factor Gene Polymorphisms on Patients with Congestive Heart Failure. Circulation, 97, 2499-2501. http://dx.doi.org/10.1161/01.CIR.97.25.2499
|
[16]
|
Bidwell, J., Keen, L., Gallagher, G., Kimberly, R., Huizinga, T., McDermott, M.F., et al. (1999) Cytokine Gene Polymorphism in Human Disease: On-Line Databases. Immunology, 1, 3-19.
|
[17]
|
Castell, J.V., Gómez-Lechón, M.J., David, M., Andus, T., Geiger, T., Trullenque, R., et al. (1989) Interleukin-6 Is the Major Regulator of Acute Phase Protein Synthesis in Adult Human Hepatocytes. FEBS Letters, 242, 237-239. http://dx.doi.org/10.1016/0014-5793(89)80476-4
|
[18]
|
Harris, T.B., Ferrucci, L., Tracy, R.P., Corti, M.C., Wacholder, S., Ettinger, W.H., et al. (1999) Associations of Elevated Interleukin-6 and C-Reactive Protein in Levels with Mortality in the Elderly. American Journal of Medicine, 106, 506-512. http://dx.doi.org/10.1016/S0002-9343(99)00066-2
|
[19]
|
Biasucci, L.M., Liuzzo, G., Grillo, R.L., Caligiuri, G., Rebuzzi, A.G., Buffon, A., et al. (1999) Elevated Levels of C-Reactive Protein at Discharge in Patients with Unstable Angina Predict Recurrent Instability. Circulation, 99, 855-860. http://dx.doi.org/10.1161/01.CIR.99.7.855
|
[20]
|
Biasucci, L.M., Liuzzo, G., Fantuzzi, G., Caligiuri, G., Rebuzzi, A.G., Ginnetti, F., et al. (1999) Increasing Levels of Interleukin (1L)-1Ra and IL-6 during the First Two Days of Hospitalization in Unstable Angina Are Associated with Increased Risk of IN-Hospital Coronary Events. Circulation, 99, 2079-2084. http://dx.doi.org/10.1161/01.CIR.99.16.2079
|
[21]
|
Tappia, P.S., Man, W.J. and Grimble, R.F. (1995) Influence of Unsaturated Fatty Acids on the Production of Tumour Necrosis Factor and Interleukin-6 by Rat Peritoneal Macrophages. Molecular and Cell Biochemistry, 143, 89-98. http://dx.doi.org/10.1007/BF01816941
|
[22]
|
Maes, M., Song, C., Lin, A., De Jongh, R., Van Gastel, A., Kenis, G., et al. (1998) The Effects of Psychological Stress on Humans: Increased Production of Pro-Inflammatory Cytokines and Th1-Like Response in Stress-Induced Anxiety. Cytokine, 10, 313-318. http://dx.doi.org/10.1006/cyto.1997.0290
|
[23]
|
Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J.S., Humphries, S., et al. (1998) The Effect of Novel Polymorphisms in the Interleukin-6 (IL-6) Gene on IL-6 Transcription and Plasma IL-6 Levels, and an Association with Systemic-Onset Juvenile Chronic Arthritis. Journal of Clinical Investigation, 102, 1369-1376. http://dx.doi.org/10.1172/JCI2629
|
[24]
|
Losito, A., Kalidas, K., Santoni, S. and Jeffery, S. (2003) Association of Interleukin-6 ﹣174G/C Promoter Polymorphism with Hypertension and Left Ventricular Hypertrophy in Dialysis Patients. Kidney International, 64, 616-622. http://dx.doi.org/10.1046/j.1523-1755.2003.00119.x
|
[25]
|
Humphries, S.E., Luong, L.A., Ogg, M.S., Hawe, E. and Miller, G.J. (2001) The Interleukin-6 174 G/C Polymorphism Is Associated with Risk of Coronary Heart Disease and Systolic Blood Pressure in Healthy Men. European Heart Journal, 22, 2243-2252. http://dx.doi.org/10.1161/hq0901.094280
|
[26]
|
Brull, D.J., Montgomery, H.E., Sanders, J., Dhamrait, S., Luong, L., Rumley, A., et al. (2001) Interleukin-6 Gene ﹣174G > C and ﹣572G > C Promoter Polymorphisms Are Strong Predictors of Plasma Interleukin-6 Levels after Coronary Artery Bypass Surgery. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 1458-1463. http://dx.doi.org/10.1161/hq0901.094280
|
[27]
|
Hussain, M., Asghar, M. and Javed, Q. (2010) Resistin Gene Promoter Region Polymorphism and the Risk of Hypertrophic Cardiomyopathy in Patients. Translational Research, 155, 142-147. http://dx.doi.org/10.1016/j.trsl.2009.10.002
|
[28]
|
Hussain, M., Bibi, S. and Javed, Q. (2011) Heritability of Genetic Variants of Resistin Gene in Patients with Coronary Artery Disease: A Family-Based Study. Clinical Biochemistry, 44, 618-622. http://dx.doi.org/10.1016/j.clinbiochem.2011.02.013
|
[29]
|
Sheth, T., Nair, C., Nargundkar, M., Anand, S. and Yusuf, S. (1999) Cardiovascular and Cancer Mortality Canadians of European, South Asian, and Chinese Origin from 1979 to 1993: An Analysis of 1.2 Million Deaths. Canadian Medical Association Journal, 161, 132-138.
|
[30]
|
McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D.R., et al. (2007) A Common Allele on Chromosome 9 Associated with Coronary Heart Disease. Science, 316, 1488-1491. http://dx.doi.org/10.1126/science.1142447
|
[31]
|
Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., et al. (2007) A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction. Science, 316, 1491-1493. http://dx.doi.org/10.1126/science.1142842
|
[32]
|
Preuss, M., Konig, I.R., Thompson, J.R., Erdmann, J., Absher, D., Assimes, T.L., et al. (2010) Design of the Coronary Artery Disease Genome-Wide Replication and Meta-Analysis (CARDIoGRAM) Study: A Genome-Wide Association Meta-Analysis Involving More than 22 000 Cases and 60 000 Controls. Circulation: Cardiovascular Genetics, 3, 1369-1376. http://dx.doi.org/10.1161/CIRCGENETICS.109.899443
|
[33]
|
Zhuang, J., Peng, W., Li, H., Wang, W., Wei, Y., Li, W. and Xu, Y. (2012) Methylation of p15INK4b and Expression of ANRIL on Chromosome 9p21 Are Associated with Coronary Artery Disease. PLoS ONE, 7, e47193. http://dx.doi.org/10.1371/journal.pone.0047193
|
[34]
|
Javed, Q. and Murtaza, I. (2013) Therapeutic Potential of Tumor Necrosis Factor-Alpha Antagonists in Patients with Chronic Heart Failure. Heart, Lung and Circulation, 22, 323-327. http://dx.doi.org/10.1016/j.hlc.2012.12.002
|